1-3 of 3
Claire Chapman
Close
Sort by
Journal Articles

Newly Diagnosed Multiple Myeloma (MM) Patients Treated With Lenalidomide Induction and Maintenance Show a Low Incidence Of Second Primary Malignancies (SPMs)

Annamaria Brioli, MD, Charlotte Pawlyn, MD, Walter Gregory, PhD, Samantha Hinsley, MSc, Samantha Marshall, Jindriska Lindsay, MD, Claire Chapman, MD, Gordon Cook, MD, PhD, Donald Milligan, MD, FRCP, FRCPath, Michele Cavo, MD, Graham H Jackson, MD, Nigel Russel, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2074.
https://doi.org/10.1182/blood.V122.21.2074.2074
Published: 2013
Journal Articles

Lenalidomide Combined With Cyclophosphamide and Dexamethasone Is Effective and Well Tolerated Induction Treatment For Newly Diagnosed Myeloma Patients Of All Ages

Charlotte Pawlyn, MD, Annamaria Brioli, MD, Walter Gregory, PhD, Samantha Hinsley, MSc, Jindriska Lindsay, MD, Gordon Cook, MD, PhD, Donald Milligan, MD, Claire Chapman, MD, Roger G Owen, MD, Mark T Drayson, MD PhD, Nigel Russell, MD, Graham H Jackson, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2013) 122 (21): 540.
https://doi.org/10.1182/blood.V122.21.540.540
Published: 2013
Journal Articles

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome

Clinical Trials & Observations
Alexander Sternberg, Sally Killick, Tim Littlewood, Chris Hatton, Andy Peniket, Thomas Seidl, Shamit Soneji, Joanne Leach, David Bowen, Claire Chapman, Graham Standen, Edwin Massey, Lisa Robinson, Bipin Vadher, Richard Kaczmarski, Riaz Janmohammed, Kim Clipsham, Andrew Carr, Paresh Vyas
Journal: Blood
Blood (2005) 106 (9): 2982–2991.
https://doi.org/10.1182/blood-2005-04-1543
Published: 2005
Includes: Supplemental data